X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (536) 536
Publication (90) 90
Book Chapter (7) 7
Conference Proceeding (3) 3
Book Review (1) 1
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pd1 (252) 252
index medicus (240) 240
immunotherapy (232) 232
oncology (215) 215
humans (185) 185
cancer (136) 136
anti-pd1 (133) 133
immunology (111) 111
melanoma (108) 108
nivolumab (105) 105
female (78) 78
pembrolizumab (76) 76
chemotherapy (73) 73
ipilimumab (72) 72
pd-l1 (72) 72
animals (64) 64
expression (63) 63
pdl1 (62) 62
lymphocytes (58) 58
t cells (56) 56
care and treatment (55) 55
male (53) 53
middle aged (52) 52
programmed cell death 1 receptor - antagonists & inhibitors (52) 52
metastasis (51) 51
metastatic melanoma (49) 49
tumors (49) 49
open-label (48) 48
survival (47) 47
aged (46) 46
pd-1 (46) 46
safety (46) 46
research (45) 45
programmed cell death 1 receptor - immunology (44) 44
antineoplastic agents - therapeutic use (43) 43
apoptosis (43) 43
immune checkpoint (43) 43
t-cells (43) 43
immune checkpoint inhibitors (42) 42
adult (40) 40
ctla4 (40) 40
lung cancer (40) 40
prognosis (39) 39
antibodies, monoclonal - therapeutic use (38) 38
immunotherapy - methods (38) 38
blockade (35) 35
neoplasms. tumors. oncology. including cancer and carcinogens (35) 35
anti-ctla4 (34) 34
antibodies (34) 34
review (34) 34
lymphocytes t (33) 33
therapy (33) 33
health aspects (32) 32
biomarkers (31) 31
mice (31) 31
medicine, research & experimental (30) 30
patients (30) 30
analysis (29) 29
article (28) 28
clinical trials (28) 28
gene expression (28) 28
cell death (27) 27
ctla-4 (27) 27
ligands (27) 27
pd-1 blockade (27) 27
antigens (26) 26
drug therapy (26) 26
medicine & public health (26) 26
neoplasms - immunology (26) 26
melanoma - drug therapy (25) 25
cancer therapies (24) 24
original research (24) 24
pharmacology & pharmacy (24) 24
tumor-infiltrating lymphocytes (24) 24
cytotoxicity (23) 23
treatment outcome (23) 23
usage (23) 23
b7-h1 antigen - immunology (22) 22
biochemistry & molecular biology (22) 22
lymphomas (22) 22
medical research (22) 22
b7-h1 antigen - antagonists & inhibitors (21) 21
cell biology (21) 21
cell lung-cancer (21) 21
dermatology (21) 21
genetic aspects (21) 21
lung cancer, non-small cell (21) 21
multicenter (21) 21
neoplasms - therapy (21) 21
tumor microenvironment (21) 21
aged, 80 and over (20) 20
antibody (20) 20
antineoplastic agents - adverse effects (20) 20
hematology (20) 20
lymphoma (20) 20
mutation (20) 20
antibodies, monoclonal, humanized - therapeutic use (19) 19
biotechnology & applied microbiology (19) 19
cancer immunotherapy (19) 19
checkpoint blockade (19) 19
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (495) 495
French (22) 22
German (6) 6
Japanese (4) 4
Spanish (4) 4
Chinese (2) 2
Hungarian (2) 2
Korean (2) 2
Czech (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 10/2018, Volume 29, Issue 10, pp. 2121 - 2128
Abstract Background We hypothesized that the abundance of PD1 mRNA in tumor samples might explain the differences in overall response rates (ORR) observed... 
Anti-PD1 | Solid tumors | Gene expression | PD1 | Immunotherapy | IMMUNE | ONCOLOGY | immunotherapy | anti-PD1 | TUMOR MUTATIONAL BURDEN | EXPRESSION | gene expression | solid tumors
Journal Article
Journal of Hematology and Oncology, 04/2017, Volume 10, Issue 1
Journal Article
Journal of immunology (Baltimore, Md. : 1950), ISSN 0022-1767, 12/2013, Volume 191, Issue 12
The PD-1/PD-Ligand pathway has been shown to limit cell mediated effector functions during chronic viral infections impeding clearance of pathogens. As a... 
PD1 blockade | SIVmac239 | soluble recombinant PD1 protein
Journal Article
Annales de Dermatologie et de Venereologie, ISSN 0151-9638, 02/2018, Volume 145, Issue 2, pp. 116 - 119
Background: Granuloma annulare as a granulomatous cutaneous reaction may be drug-induced. Immune checkpoint inhibitors including programmed death-1 (PD-1)... 
Granuloma annulare | Melanoma | Anti-PD1
Journal Article
Revue Neurologique, ISSN 0035-3787, 04/2018, Volume 174, pp. S57 - S58
Journal Article
European Journal of Cancer, ISSN 0959-8049, 11/2019, Volume 122, pp. 22 - 41
Journal Article
The Oncologist, ISSN 1083-7159, 10/2018, Volume 23, Issue 10, pp. 1236 - 1241
This article reports the incidence of new‐onset thyroid function test abnormalities in patients undergoing treatment with ipilimumab, nivolumab, pembrolizumab,... 
Anti‐CTLA 4 | Pembrolizumab | Ipilimumab | Nivolumab | Anti‐PD1 | Thyroid | Anti-CTLA 4 | Anti-PD1 | UNTREATED MELANOMA | ONCOLOGY | HYPOPHYSITIS | ADVERSE EVENTS | Endocrinology
Journal Article
Journal of Immunotherapy, ISSN 1524-9557, 11/2014, Volume 38, Issue 1, pp. 37 - 39
Journal Article
Oncotarget, ISSN 1949-2553, 02/2017, Volume 8, Issue 31, pp. 51936 - 51945
The use of immune checkpoint inhibitors for the treatment of cancer is revolutionizing oncology. Amongst these therapeutic agents, antibodies that block... 
PD-L1 | B7-H1 | PD1 | PDL1 | Cancer | ACTIVATION | PROTEIN | PROGRAMMED DEATH-1 | KINASE | CBL | CELL BIOLOGY | DOWN-MODULATION | PD-L1 CO-STIMULATION | cancer | NIVOLUMAB | BLOCKADE | ANTIGEN
Journal Article
Dermatology, ISSN 1018-8665, 05/2019, Volume 235, Issue 3, pp. 219 - 224
Background: Programmed cell death protein-1 (PD-1) inhibitors (pembrolizumab and nivolumab) have been approved for the treatment of advanced melanoma. Over the... 
Skin Cancer – Research Article | Pembrolizumab | Octogenarians | Anti-PD1 | Melanoma | DERMATOLOGY
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2019, Volume 25, Issue 1, pp. 290 - 299
Purpose: Glioblastoma (GBM) is resistant to standard of care. Immune checkpoints inhibitors (such as anti-PD-1 mAbs) efficiently restore antitumor T-cell... 
TRIAL | MUTANT | HSV-1 | REPLICATION | G207 | ONCOLOGY | GLIOMA | CTLA-4 | PD1 | CHECKPOINT BLOCKADE
Journal Article
Immunobiology, ISSN 0171-2985, 05/2019, Volume 224, Issue 3, pp. 388 - 396
We recently identified a novel alternatively spliced isoform of human programmed cell death 1 (PD-1), named Δ42PD1, which contains a 42-base-pair in-frame... 
Δ42PD1 | JAK/STAT | Monocyte | Interferon-γ | PD-1 | PI3K/AKT
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 09/2018, Volume 105, Issue 9, pp. 736 - 737
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.